Page last updated: 2024-10-26

etidronate and Besnier-Boeck Disease

etidronate has been researched along with Besnier-Boeck Disease in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, T1
Inoue, Y1
Hayashi, S1
Yamamoto, S1
Sakatani, M1
Naito, T1
Nitta, K1
Kimata, N1
Honda, K1
Yoshida, T1
Koinuma, M1
Ikeda, Y1
Kato, Y1
Nihei, H1

Other Studies

2 other studies available for etidronate and Besnier-Boeck Disease

ArticleYear
Risedronate induced BOOP complicated with sarcoidosis.
    Thorax, 2005, Volume: 60, Issue:7

    Topics: Aged; Calcium Channel Blockers; Cryptogenic Organizing Pneumonia; Etidronic Acid; Female; Humans; Mu

2005
Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on haemodialysis treatment.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:11

    Topics: Adult; Calcinosis; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Glucocorticoids; Humans; L

1999